These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
590 related articles for article (PubMed ID: 11401753)
1. Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)? Melnick RL Environ Health Perspect; 2001 May; 109(5):437-42. PubMed ID: 11401753 [TBL] [Abstract][Full Text] [Related]
2. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines. Doull J; Cattley R; Elcombe C; Lake BG; Swenberg J; Wilkinson C; Williams G; van Gemert M Regul Toxicol Pharmacol; 1999 Jun; 29(3):327-57. PubMed ID: 10388618 [TBL] [Abstract][Full Text] [Related]
3. Weight-of-evidence versus strength-of-evidence in toxicologic hazard identification: Di(2-ethylhexyl)phthalate (DEHP). Willhite CC Toxicology; 2001 Mar; 160(1-3):219-26. PubMed ID: 11246142 [TBL] [Abstract][Full Text] [Related]
4. Mechanistic considerations for human relevance of cancer hazard of di(2-ethylhexyl) phthalate. Rusyn I; Corton JC Mutat Res; 2012; 750(2):141-158. PubMed ID: 22198209 [TBL] [Abstract][Full Text] [Related]
5. Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk. Huber WW; Grasl-Kraupp B; Schulte-Hermann R Crit Rev Toxicol; 1996 Jun; 26(4):365-481. PubMed ID: 8817083 [TBL] [Abstract][Full Text] [Related]
6. Chronic peroxisome proliferation and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)phthalate and the effects of recovery. David RM; Moore MR; Cifone MA; Finney DC; Guest D Toxicol Sci; 1999 Aug; 50(2):195-205. PubMed ID: 10478855 [TBL] [Abstract][Full Text] [Related]
7. Characterization of peroxisome proliferator-activated receptor alpha--independent effects of PPARalpha activators in the rodent liver: di-(2-ethylhexyl) phthalate also activates the constitutive-activated receptor. Ren H; Aleksunes LM; Wood C; Vallanat B; George MH; Klaassen CD; Corton JC Toxicol Sci; 2010 Jan; 113(1):45-59. PubMed ID: 19850644 [TBL] [Abstract][Full Text] [Related]
8. PPAR: a mediator of peroxisome proliferator action. Green S Mutat Res; 1995 Dec; 333(1-2):101-9. PubMed ID: 8538617 [TBL] [Abstract][Full Text] [Related]
9. Effects of Di-2-ethylhexyl phthalate (DEHP) on gap-junctional intercellular communication (GJIC), DNA synthesis, and peroxisomal beta oxidation (PBOX) in rat, mouse, and hamster liver. Isenberg JS; Kamendulis LM; Smith JH; Ackley DC; Pugh G; Lington AW; Klaunig JE Toxicol Sci; 2000 Jul; 56(1):73-85. PubMed ID: 10869455 [TBL] [Abstract][Full Text] [Related]
10. Species differences in response to diethylhexylphthalate: suppression of apoptosis, induction of DNA synthesis and peroxisome proliferator activated receptor alpha-mediated gene expression. Hasmall SC; James NH; Macdonald N; Soames AR; Roberts RA Arch Toxicol; 2000 Apr; 74(2):85-91. PubMed ID: 10839475 [TBL] [Abstract][Full Text] [Related]
11. Di(2-ethylhexyl) phthalate induces apoptosis through peroxisome proliferators-activated receptor-gamma and ERK 1/2 activation in testis of Sprague-Dawley rats. Ryu JY; Whang J; Park H; Im JY; Kim J; Ahn MY; Lee J; Kim HS; Lee BM; Yoo SD; Kwack SJ; Oh JH; Park KL; Han SY; Kim SH J Toxicol Environ Health A; 2007 Aug; 70(15-16):1296-303. PubMed ID: 17654247 [TBL] [Abstract][Full Text] [Related]
12. Rodent carcinogenicity of peroxisome proliferators and issues on human relevance. Lai DY J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2004 May; 22(1):37-55. PubMed ID: 15845221 [TBL] [Abstract][Full Text] [Related]
13. Effects of the peroxisome proliferator di(2-ethylhexyl)phthalate on cell turnover and peroxisome proliferation in primary chick embryo hepatocytes. Arias E Environ Toxicol Chem; 2012 Dec; 31(12):2856-60. PubMed ID: 23001933 [TBL] [Abstract][Full Text] [Related]
14. Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver. Rusyn I; Peters JM; Cunningham ML Crit Rev Toxicol; 2006 May; 36(5):459-79. PubMed ID: 16954067 [TBL] [Abstract][Full Text] [Related]
15. Ability of peroxisome proliferators to induce cell transformation, chromosome aberrations and peroxisome proliferation in cultured Syrian hamster embryo cells. Tsutsui T; Watanabe E; Barrett JC Carcinogenesis; 1993 Apr; 14(4):611-8. PubMed ID: 8472324 [TBL] [Abstract][Full Text] [Related]
16. Effects of the environmental contaminants DEHP and TCDD on estradiol synthesis and aryl hydrocarbon receptor and peroxisome proliferator-activated receptor signalling in the human granulosa cell line KGN. Ernst J; Jann JC; Biemann R; Koch HM; Fischer B Mol Hum Reprod; 2014 Sep; 20(9):919-28. PubMed ID: 24950685 [TBL] [Abstract][Full Text] [Related]
17. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. Marsman DS; Cattley RC; Conway JG; Popp JA Cancer Res; 1988 Dec; 48(23):6739-44. PubMed ID: 3180084 [TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor (PPAR) alpha activation and its consequences in humans. Hertz R; Bar-Tana J Toxicol Lett; 1998 Dec; 102-103():85-90. PubMed ID: 10022237 [TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferators: their biological and toxicological effects. Dzhekova-Stojkova S; Bogdanska J; Stojkova Z Clin Chem Lab Med; 2001 Jun; 39(6):468-74. PubMed ID: 11506454 [TBL] [Abstract][Full Text] [Related]
20. Kupffer cell oxidant production is central to the mechanism of peroxisome proliferators. Rose ML; Rivera CA; Bradford BU; Graves LM; Cattley RC; Schoonhoven R; Swenberg JA; Thurman RG Carcinogenesis; 1999 Jan; 20(1):27-33. PubMed ID: 9934846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]